Could an existing antiviral ease long COVID? small study tests remdesivir
NCT ID NCT05911906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the antiviral drug remdesivir could help people with Long COVID. 73 adults with confirmed Long COVID received five daily doses of the drug through an IV. Researchers measured how many people completed the treatment and tests, and how well they tolerated it. The goal was to see if a larger trial is possible, not to prove the drug works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remdesivir (an antiviral drug given intravenously)
What this could lead to
If this works, it could point toward a treatment that reduces Long COVID symptoms and improves quality of life.
What could go wrong
This is a small feasibility study, not a large trial. It focuses on whether the drug can be given practically, not on proving it works. Many people with Long COVID may not benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Derbyshire Community Health Services NHS Foundation Trust
Chesterfield, S42 7JE, United Kingdom
-
Royal Derby Hospital (UHDB)
Derby, D22 3NE, United Kingdom
-
University of Derby
Derby, Derby, DE22 1GB, United Kingdom
-
University of Exeter / Royal Devon University Healthcare NHS FT
Exeter, EX4 4PY, United Kingdom